| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/27/2002 | US6440985 Methods for treating viral infections |
| 08/27/2002 | US6440941 Derivatives of erythromycin, their preparation process and their use as medicaments |
| 08/27/2002 | US6440588 1,4-diazepine compound with electron attractive group selected from the group consisting of cyano group, an acyl group, and an alkoxy group |
| 08/27/2002 | CA2045955C Indole derivatives |
| 08/22/2002 | WO2002064586A2 Heterocyclic inhibitors of erk2 and uses thereof |
| 08/22/2002 | WO2002064573A1 Novel carboxylic acid derivatives containing alkyl substituted triazines, production of the same and use thereof as endothelin receptor antagonists |
| 08/22/2002 | WO2002064572A1 Quinazolines as mmp-13 inhibitors |
| 08/22/2002 | WO2002064559A2 Thrombin inhibitors |
| 08/22/2002 | WO2002064550A1 Glucocorticoid receptor modulators |
| 08/22/2002 | WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals |
| 08/22/2002 | WO2002064140A1 Thrombin inhibitors |
| 08/22/2002 | WO2002064135A1 Heterocyclic inhibitors of glycine transporter 2 |
| 08/22/2002 | WO2002064119A1 Tablets quickly disintegrated in oral cavity |
| 08/22/2002 | WO2002063957A2 Selective substituted aryl ketone and safener based herbicides |
| 08/22/2002 | WO2002045652A3 Tyrosine kinase inhibitors |
| 08/22/2002 | WO2002040471A3 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 08/22/2002 | US20020115868 Novel process for making 5-substituted pyrazoles |
| 08/22/2002 | US20020115863 Hydroxamate derivatives that inhibit peptidyl deformylase (PDF), antimicrobials and antibiotics |
| 08/22/2002 | US20020115859 Of the class 3,3,5,5-tetramethyl-2-oxo-1,4-piperazine, polymers thereof; stabilizers for thermoplastic organic polymers, coating compositions or photographic materials |
| 08/22/2002 | US20020115702 Administering substituted imidazoles, particular by losartan potassium, treatment of post-transplant hypertension. |
| 08/22/2002 | US20020115685 Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/22/2002 | US20020115674 Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents |
| 08/22/2002 | US20020115670 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 08/22/2002 | US20020115668 Having HIV replication inhibiting properties. |
| 08/22/2002 | US20020115653 Retinoic acid mimetic anilides |
| 08/22/2002 | US20020115567 Substituted 2-amino-1,3,5-triazines, their preparation, and their use as herbicides and plant growth regulators |
| 08/22/2002 | CA2437760A1 Selective substituted aryl ketone and safener based herbicides |
| 08/22/2002 | CA2437122A1 Quinazolines as mmp-13 inhibitors |
| 08/22/2002 | CA2436176A1 Thrombin inhibitors |
| 08/22/2002 | CA2436079A1 Heterocyclic inhibitors of glycine transporter 2 |
| 08/22/2002 | CA2436068A1 Thrombin inhibitors |
| 08/21/2002 | EP1233015A1 Use of imidazole derivatives for the treatement of deseases involving the AT1 and AT2s receptors of angiotensine, some of these products, their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 08/21/2002 | EP1232153A2 Imidazole derivatives and their use as raf kinase inhibitors |
| 08/21/2002 | EP1232147A1 Triazoles as farnesyl transferase inhibitors |
| 08/21/2002 | EP1231982A2 Use of phthalazine derivatives |
| 08/21/2002 | EP1053224B1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
| 08/21/2002 | EP0696194B1 Use of indole derivatives as 5ht1 antagonists |
| 08/21/2002 | CN1365356A Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 08/20/2002 | US6437129 Armoatic or heteroarmoatic compound containing substituted amides or thioamides |
| 08/20/2002 | US6436985 Disubstituted pyrazolines and triazolines as factor Xa inhibitors |
| 08/20/2002 | US6436982 Benzimidazole derivatives |
| 08/20/2002 | US6436981 Dihydrotriazolone derivatives as pesticides |
| 08/20/2002 | US6436974 Heterocyclic amines used as antiepileptic, antiischemic, analgesic and anxiolytic agents; prophylaxis of dyskinesia, brain, nerveous system and sleep disorders |
| 08/20/2002 | US6436965 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 08/20/2002 | US6436957 Indole derivatives as 5-HT1 agonists |
| 08/20/2002 | US6436941 Treating schizophrenia, depression, and parkinson's disease; side effect reduction |
| 08/20/2002 | US6436939 Treatment of central nervous system disorders including sleep/wake disorders, dementia, alzheimer's disease, epilepsy, narcolepsy, eating disorders, motion sickness, vertigo |
| 08/20/2002 | US6436928 Selective neurokinin antagonists |
| 08/20/2002 | US6436915 Antiproliferative and antitumor agents and angiogenesis inhibitors |
| 08/20/2002 | US6436904 Treatment of inflammatory diseases in mammals |
| 08/20/2002 | CA2088367C Tri- and tetra-valent monospecific antigen-binding proteins |
| 08/15/2002 | WO2002062796A1 Epindolidione pigments |
| 08/15/2002 | WO2002062792A1 Jnk inhibitor |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062755A2 Polyamide analogs as dna minor groove binders |
| 08/15/2002 | WO2002062423A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 08/15/2002 | WO2002062290A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| 08/15/2002 | WO2001030768A9 Methods and compositions utilizing quinazolinones |
| 08/15/2002 | US20020111461 Peptidomimetic compound for us ein the treatment of diabetes |
| 08/15/2002 | US20020111374 Estrogen receptor modulators |
| 08/15/2002 | US20020111371 Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke |
| 08/15/2002 | US20020111357 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 08/15/2002 | US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders |
| 08/15/2002 | US20020111348 Substituted oximes and hydrazones as neurokinin antagonists |
| 08/15/2002 | US20020111274 Controlling plants |
| 08/15/2002 | CA2437248A1 Jnk inhibitor |
| 08/14/2002 | EP1231210A2 Azole antifungal agents, processes for the preparation thereof, and intermediates |
| 08/14/2002 | EP1230225A2 Pharmaceutically active 4-substituted pyrimidine derivatives |
| 08/14/2002 | EP1230224A1 Substituted 5-benzyl-2,4-diaminopyrimidines |
| 08/14/2002 | EP1229907A1 Prevention of plaque rupture by acat inhibitors |
| 08/14/2002 | EP0722439B1 Hiv protease inhibitors |
| 08/14/2002 | EP0535034B1 Pharmaceutically active benzoquinazoline compounds |
| 08/14/2002 | DE10106420A1 Selektive Herbizide auf Basis von substituierten Arylketonen und Safenern Selective herbicides based on substituted aryl ketones and safeners |
| 08/14/2002 | CN1364167A Endogenous constitutively activated G protein-coupled orphan receptors |
| 08/14/2002 | CN1364166A Polymorphic salt as medicine for migraine |
| 08/14/2002 | CN1364157A N-(indolcarbonyl) piperazin derivatives |
| 08/14/2002 | CN1089008C In-vivo diagnostic process by near infrared radiation |
| 08/13/2002 | US6433185 N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/13/2002 | US6433002 Pesticidal 1-polyarylpyrroles |
| 08/13/2002 | US6432997 Systemic insecticides, nematocides, larvicides, miticides, and anthelmintics; agriculture, horticulture |
| 08/13/2002 | US6432996 Pharmaceutical composition |
| 08/13/2002 | US6432969 Non-insulin dependent diabetes, obesity, arthritis, and osteoporosis treatment |
| 08/13/2002 | US6432963 Antiinflammatory agents; tyrosine kinase inhibitor |
| 08/13/2002 | US6432959 Antitumor agents |
| 08/13/2002 | US6432947 N-heterocyclic derivatives as NOS inhibitors |
| 08/13/2002 | US6432921 Oligopeptides |
| 08/13/2002 | CA2216633C Synthesis of bis-indolylmaleimides |
| 08/08/2002 | WO2002060974A1 Polymers |
| 08/08/2002 | WO2002060895A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | WO2002060879A2 Bacterial gyrase inhibitors and uses thereof |
| 08/08/2002 | WO2002060877A1 Imidazole derivatives |
| 08/08/2002 | WO2002060869A2 Use of p38 inhibitors for the treatment of inflammation-enhanced cough |
| 08/08/2002 | WO2002060867A2 Carbazole derivatives and their uses as heparanase inhibitors |
| 08/08/2002 | WO2002060447A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | WO2002060438A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | WO2002060392A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 08/08/2002 | WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2002024690A8 Efficient process for the preparation of a factor xa inhibitor |